Kailera Therapeutics, Inc. (KLRA)
16.54
-0.63
(-3.67%)
USD |
NASDAQ |
Aug 24, 16:00
16.54
0.00 (0.00%)
After-Hours: 20:00
Kailera Therapeutics Debt to Equity Ratio : 0.0091 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0091 |
| Date | Value |
|---|---|
| March 31, 2026 | 0.0187 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Moderna, Inc. | 0.1904 |
| Revolution Medicines, Inc. | 0.4568 |
| Sana Biotechnology, Inc. | 0.4771 |
| Parabilis Medicines, Inc. | 0.0453 |
| Arrowhead Pharmaceuticals, Inc. | 2.956 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 1.211B |
| Total Liabilities (Quarterly) | 92.95M |
| Shareholders Equity (Quarterly) | 1.118B |
| Current Ratio | 11.11 |